Inhibiting the JNK/p38 MAPK signaling pathway can attenuate cisplatin-induced apoptosis of ovarian cancer cells, suggesting that the JNK/p38 MAPK signaling pathway is involved in the response of tumor cells to cisplatin (8). Here, MAPK8 is linked to ovarian carcinoma.